ABSTRACT

WHO estimates that hepatitis E caused approximately 44000 deaths in 2015 (accounting for 3.3% of the mortality due to viral hepatitis). The virus is transmitted via the fecal-oral route, principally via contaminated water. Even though HEV infection is self-limiting condition, in immunosuppressed patients it can be fatal due to the liver damage. An alternate solution for management of HEV infection is much needed. In this case study an HEV patient was given Kamala treatment and it is observed that elevated levels of HEVIgm, Bilirubin, SGOT, SGPT, and ALP were reduced after the 28 days. Keywords: Hepattis E, HEVIgm, Ayurvedic management, SGOT, ALP, Kamala
Publication date: 25/01/2022

https://ijbpas.com/pdf/2022/January/MS_IJBPAS_2022_JAN_SPCL_2_2060.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2022/11.1.2060